Top

European Journal of Clinical Microbiology & Infectious Diseases

Published in:

01-04-2019 | Antibiotic | Original Article

Discordant isolates in bone specimens from patients with recurrent foot osteomyelitis

Authors: Neal R. Barshes, Cezarina Mindru, Barbara W. Trautner, Maria C. Rodriguez-Barradas

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 4/2019

Abstract

We compared paired operative bone cultures (initial operation and reoperation) for 35 patients who experienced foot osteomyelitis treatment failure at a single hospital. Concordance was poor (kappa = 0.180). Staphylococcus aureus, gram negatives, and anaerobes were the most common discordant bacteria seen at reoperation, while Enterococcus was the most persistent.

Embil JM, Rose G, Trepman E, Math MCM, Duerksen F, Simonsen JN et al (2006) Oral antimicrobial therapy for diabetic foot osteomyelitis. Foot Ankle Int Am Orthop Foot Ankle Soc Swiss Foot Ankle Soc 27(10):771–779CrossRef

Game FL, Jeffcoate WJ (2008) Primarily non-surgical management of osteomyelitis of the foot in diabetes. Diabetologia 51(6):962–967CrossRefPubMed

Barshes NR, Mindru C, Ashong C, Rodriguez-Barradas M, Trautner BW (2016) Treatment failure and leg amputation among patients with foot osteomyelitis. Int J Low Extrem Wounds 15(4):303–312CrossRefPubMed

van Asten SA, La Fontaine J, Peters EJG, Bhavan K, Kim PJ, Lavery LA (2016) The microbiome of diabetic foot osteomyelitis. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 35(2):293–298CrossRef

Gardner SE, Hillis SL, Heilmann K, Segre JA, Grice EA (2013) The neuropathic diabetic foot ulcer microbiome is associated with clinical factors. Diabetes 62(3):923–930CrossRefPubMedPubMedCentral

Loesche M, Gardner SE, Kalan L, Horwinski J, Zheng Q, Hodkinson BP et al (2017) Temporal stability in chronic wound microbiota is associated with poor healing. J Invest Dermatol 137(1):237–244CrossRefPubMed

Berendt AR, Peters EJG, Bakker K, Embil JM, Eneroth M, Hinchliffe RJ et al (2008) Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev 24(Suppl 1):S145–S161CrossRefPubMed

Daum RS, Miller LG, Immergluck L, Fritz S, Creech CB, Young D et al (2017) A placebo-controlled trial of antibiotics for smaller skin abscesses. N Engl J Med 376(26):2545–2555CrossRefPubMed

Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJG, Armstrong DG et al (2012) 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis Off Publ Infect Dis Soc Am 54(12):e132–e173CrossRef

10.

Senneville E, Lombart A, Beltrand E, Valette M, Legout L, Cazaubiel M et al (2008) Outcome of diabetic foot osteomyelitis treated nonsurgically: a retrospective cohort study. Diabetes Care 31(4):637–642CrossRefPubMed

11.

Kalan L, Loesche M, Hodkinson BP, Heilmann K, Ruthel G, Gardner SE, Grice EA (2016) Redefining the chronic-wound microbiome: fungal communities are prevalent, dynamic, and associated with delayed healing. MBio 7(5):e01058-16. https://doi.org/10.1128/mBio.01058-16

Title: Discordant isolates in bone specimens from patients with recurrent foot osteomyelitis
Authors: Neal R. Barshes
Cezarina Mindru
Barbara W. Trautner
Maria C. Rodriguez-Barradas
Publication date: 01-04-2019
Publisher: Springer Berlin Heidelberg
Keywords: Antibiotic
Diabetic Foot
Osteomyelitis
Published in: European Journal of Clinical Microbiology & Infectious Diseases / Issue 4/2019
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-019-03470-w

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2019

The role of therapy with aminoglycoside in the outcomes of kidney transplant recipients infected with polymyxin- and carbapenem-resistant Enterobacteriaceae

Clinical features and cause analysis of false positive results of Aspergillus galactomannan assay in pulmonary cryptococcosis patients

Predictive factors of hepatitis C virus eradication after interferon-free therapy in HIV coinfection

A systematic review on efficiency of microneme proteins to induce protective immunity against Toxoplasma gondii

The joint impact of smoking plus alcohol drinking on treatment of pulmonary tuberculosis

Detection of Enterobius vermicularis in greater Berlin, 2007–2017: seasonality and increased frequency of detection

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials